Change in Cognition-Specific Medications After 3 Months
Change in cognition-specific medications was similar in the 3 study arms: 37 of 253 participants (15%) in arm 1 changed medications, 36 of 259 (14%) in arm 2, and 38 of 262 (15%) in arm 3 (In arm 1 and arm 3, change in cognition-specific medications occurred more frequently after positive rather than negative amyloid PET (arm 1: 31/37, 84%, vs 6/37, 16%; 